3 | SEC Filings Hub

Filing metadata

Accession number: 0001140361-23-031954
Form type: Form 3
Filer: Acrivon Therapeutics, Inc.
CIK: CIK 1781174
Filed: Jun 28, 2023
Reporting period: Jun 22, 2023
Description: Initial ownership

Documents

0001140361-23-031954-index.htm

Complete submission

0001140361-23-031954.txt

directory listing

Filed by

Acrivon Therapeutics, Inc.